This article is a correction to:
Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
Chao Xia1,2†Wei Huang1†Yun-Liang Chen3Hai-Bin Fu2Ming Tang2Tao-Lan Zhang2Jing Li4Guo-Hua Lv4Yi-Guo Yan2Zhi-Hua Ouyang2Nvzhao Yao2Cheng Wang2*
Ming-Xiang Zou2*- 1The First Affiliated Hospital, Health Management Center, Hengyang Medical School, University of South China, Hengyang, China
- 2Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
- 3Shenzhen Audaque Data Technology Co., Ltd., Shenzhen, China
- 4Department of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
A corrigendum on
Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients
by Xia C, Huang W, Chen Y-L, Fu H-B, Tang M, Zhang T-L, Li J, Lv G-H, Yan Y-G, Ouyang Z-H, Yao N, Wang C and Zou M-X (2022) Front. Immunol. 12:797407. doi: 10.3389/fimmu.2021.797407
In the published article, there was an error in the author list, and Prof. Ming-Xiang Zou was erroneously denoted as the only corresponding author of this article. Prof. Cheng Wang should be denoted as the co-corresponding author for this paper. In addition, Prof. Cheng Wang and Prof. Ming-Xiang Zou should not have been marked with the † symbol. The corrected author list appears below.
Chao Xia1,2†, Wei Huang1†, Yun-Liang Chen3, Hai-Bin Fu2, Ming Tang2, Tao-Lan Zhang2, Jing Li 4, Guo-Hua Lv4, Yi-Guo Yan2, Zhi-Hua Ouyang2, Nvzhao Yao2, Cheng Wang2* and Ming-Xiang Zou2*
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: spinal chordoma, immune checkpoint molecules, quantitative immunofluorescence, HHLA2, PD-L1, tumor infiltrating lymphocytes
Citation: Xia C, Huang W, Chen Y-L, Fu H-B, Tang M, Zhang T-L, Li J, Lv G-H, Yan Y-G, Ouyang Z-H, Yao N, Wang C and Zou M-X (2023) Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients. Front. Immunol. 14:1194064. doi: 10.3389/fimmu.2023.1194064
Received: 26 March 2023; Accepted: 27 March 2023;
Published: 14 April 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Xia, Huang, Chen, Fu, Tang, Zhang, Li, Lv, Yan, Ouyang, Yao, Wang and Zou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cheng Wang, 2598166583@qq.com; Ming-Xiang Zou, zouwei8887@126.com
†These authors have contributed equally to this work